Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03251729 · ClinicalTrials.gov registry record · Phase 4
Cerclage On LOw Risk Singletons: Cervical Cerclage for Prevention of Spontaneous Preterm Birth in Low Risk Singleton Pregnancies With Short Cervix
A Phase 4 study, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- Phase 4
- Development phase
- 93
- Enrollment target
NCT03251729 is a Phase 4 study that has completed, run by Thomas Jefferson University. The registered enrollment target is 93 participants.
The verdict
NCT03251729, a Phase 4 study, has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 93 participants
- Enrollment target
Study Summary
The aim of this study is to evaluate the efficacy of cervical cerclage in prevention of spontaneous preterm birth in singleton pregnancies with a short transvaginal cervical length (\<=25mm) and without prior spontaneous preterm birth
Interventions
- PROCEDURE Cervical cerclage
- DRUG Vaginal progesterone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2017-09-22 |
| Est. Completion | 2024-02-20 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03251729
The ClinicalTrials.gov registry entry for NCT03251729 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cervical cerclage is the first listed.
NCT03251729 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03251729 about?
NCT03251729 is a clinical study titled "Cerclage On LOw Risk Singletons: Cervical Cerclage for Prevention of Spontaneous Preterm Birth in Low Risk Singleton Pregnancies With Short Cervix". The aim of this study is to evaluate the efficacy of cervical cerclage in prevention of spontaneous preterm birth in singleton pregnancies with a short transvaginal cervical length (\<=25mm) and without prior spontaneous preterm birth
What is the current status of trial NCT03251729?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 93 participants. The study started on 2017-09-22. Estimated completion is 2024-02-20.
What interventions are being tested in trial NCT03251729?
The interventions under investigation include: Cervical cerclage (PROCEDURE), Vaginal progesterone (DRUG).
Who is sponsoring clinical trial NCT03251729?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.